BrainCheck (a digital health innovator growing in the digital cognitive assessment market) announced a $15 million new financing round led by Next Coast Ventures, S3 Ventures, and UPMC Enterprises (the venture capital arm of UPMC). The company also expanded its Board of Directors by appointing Nicholas Shapiro, Vice President of UPMC Enterprises, as a new board member, further driving its strategic leadership.
This funding round will accelerate BrainCheck’s commercial traction, expand innovation within its product portfolio, build upon existing clinical evidence, and extend its impact throughout the healthcare landscape, including major integrations with healthcare systems. And this announcement follows the recent launch of BrainCheck’s next-generation platform and 3-minute screening solution, enabling clinicians to screen and monitor patients’ cognitive function anytime, anywhere.
Used by hundreds of the country’s most prestigious providers and specialists, BrainCheck’s platform is the most comprehensive solution commercially available across the cognitive care continuum, streamlining screening, assessment, care planning and monitoring.
KEY QUOTES:
“We are laser focused on commercializing and scaling a digital cognitive assessment platform that is clinically robust, easy for patients and their caregivers to use, enables a simplified provider experience and improves access to the actionable information needed to intervene sooner and potentially combat cognitive decline. We thank our current and new investors for their continued support and look forward to deploying this capital to play an important role in revolutionizing cognitive care.”
– Kim Rodriguez, CEO of BrainCheck
“We believe in BrainCheck’s vision to pioneer a fundamental shift in how cognitive care is delivered. Dementia is projected to impact 14 million people in the United States and 152 million globally in the coming decades, underscoring the importance of proactive measures to address prevention, early detection, and effective management strategies.”
– Michael Smerklo, Co-Founder and Managing Partner of Next Coast Ventures
“Our decision to invest in BrainCheck is fueled by a deep understanding of the pressing burden of cognitive impairment on health care and the exciting solutions on the horizon to advance the industry. I am honored to join BrainCheck’s Board of Directors and look forward to working collaboratively with the team to drive strategic initiatives and shape the future growth trajectory of the company. BrainCheck’s solutions offer rapid, reliable resources to support accurate assessments, stratify individual risk, and deliver actionable insights that can help all stakeholders – patients, caregivers, providers, and risk-bearers.”
– Nicholas Shapiro, Vice President, UPMC Enterprises
